PF-06648671
Modify Date: 2025-08-25 11:25:37
PF-06648671 structure
|
Common Name | PF-06648671 | ||
|---|---|---|---|---|
| CAS Number | 1587727-31-8 | Molecular Weight | 538.928 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H23ClF4N4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PF-06648671PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease. Alzheimer Disease Phase 1 Discontinued |
| Name | PF-06648671 |
|---|
| Description | PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease. Alzheimer Disease Phase 1 Discontinued |
|---|---|
| References | References View Related Products by Target γ-secretase Alzheimer Disease |
| Molecular Formula | C25H23ClF4N4O3 |
|---|---|
| Molecular Weight | 538.928 |